Recombinant Trivalent Rotavirus Subunit Vaccine

Rotavirus subunit vaccine (recombinant, trivalent) · MAXVAX Biotechnology Limited Liability Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Trivalent Rotavirus Subunit Vaccine, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers [Phase 2]

See pricing